Nieuwe mogelijkheden bij Clostridium difficile-infecties

Translated title of the contribution: New treatment options for infections with Clostridium difficile

Els van Nood, Josbert J. Keller, Ed J. Kuijper, Peter Speelman

Research output: Contribution to journalReview articleProfessionalpeer-review

4 Citations (Scopus)


Currently available broad spectrum antibiotics are not sufficiently effective against recurrent Clostridium difficile infections (CDI). Donor faecal microbiota transplantation is a very effective treatment for second and recurrent infection but is time-consuming and requires careful screening of donors. The new narrow spectrum antibiotic fidaxomicin is a good alternative in a first CDI or a first recurrence, but treatment is expensive and there are no data on its effectiveness in a second or later recurrence. Fidaxomicin is less effective against infections caused by the Ribotype 027 strain, a virulent strain that is regularly encountered in the Netherlands. The effectiveness of various other promising narrow spectrum antibiotics is currently being investigated. Medications that support the gut flora or the immune system seem to offer new perspectives. Expectations for the currently available probiotic preparations and toxin binders are not high.

Translated title of the contributionNew treatment options for infections with Clostridium difficile
Original languageDutch
Article numberA6580
JournalNederlands Tijdschrift voor Geneeskunde
Issue number48
Publication statusPublished - 25 Nov 2013
Externally publishedYes


Dive into the research topics of 'New treatment options for infections with Clostridium difficile'. Together they form a unique fingerprint.

Cite this